Total Payments
$617.63
2024 Payments
$91.27
Companies
9
Transactions
18
Medicare Patients
2,115
Medicare Billing
$110,313
Payment Breakdown by Category
Food & Beverage$617.63 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $617.63 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $170.21 | 3 | $0 (2023) |
| ABBVIE INC. | $140.64 | 3 | $0 (2022) |
| PFIZER INC. | $93.59 | 3 | $0 (2023) |
| VERTEX PHARMACEUTICALS INCORPORATED | $53.41 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $52.17 | 2 | $0 (2022) |
| LEO Pharma Inc. | $49.00 | 2 | $0 (2023) |
| Smith+Nephew, Inc. | $23.07 | 1 | $0 (2024) |
| Amgen Inc. | $20.75 | 1 | $0 (2022) |
| Medtronic, Inc. | $14.79 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $91.27 | 4 | VERTEX PHARMACEUTICALS INCORPORATED ($53.41) |
| 2023 | $168.99 | 4 | GENZYME CORPORATION ($116.69) |
| 2022 | $357.37 | 10 | ABBVIE INC. ($140.64) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $31.96 | General |
| 08/21/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $21.45 | General |
| 08/16/2024 | Medtronic, Inc. | LIGASURE (Device) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Vessel Sealing | ||||||
| 06/20/2024 | Smith+Nephew, Inc. | Iodosorb Ointment 40g USA (Device), COLLAGENASE SANTYL | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Infection Management | ||||||
| 05/25/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: DERMATOLOGY | ||||||
| 04/27/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $116.69 | General |
| Category: Immunology | ||||||
| 02/28/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: DERMATOLOGY | ||||||
| 02/06/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: DERMATOLOGY | ||||||
| 12/07/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2022 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: Immunology | ||||||
| 10/13/2022 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $67.07 | General |
| Category: Inflammation & Immunology | ||||||
| 09/27/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Immunology | ||||||
| 09/15/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.84 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: DERMATOLOGY | ||||||
| 07/22/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/17/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: IMMUNOLOGY | ||||||
| 06/15/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Inflammation | ||||||
| 03/24/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 575 | 907 | $96,560 | $23,134 |
| 2022 | 11 | 1,188 | 1,815 | $214,092 | $66,556 |
| 2021 | 7 | 341 | 479 | $57,289 | $19,540 |
| 2020 | 1 | 11 | 21 | $3,192 | $1,082 |
Total Patients
2,115
Total Services
3,222
Medicare Billing
$110,313
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 204 | 222 | $38,259 | $9,091 | 23.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 101 | 108 | $14,009 | $3,180 | 22.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 50 | 50 | $9,866 | $2,594 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 39 | $9,487 | $2,174 | 22.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 42 | 43 | $9,479 | $2,029 | 21.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 82 | 375 | $4,863 | $1,539 | 31.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $6,620 | $1,368 | 20.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 15 | 23 | $2,246 | $779.44 | 34.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $1,732 | $379.79 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 367 | 404 | $71,062 | $22,568 | 31.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 119 | 130 | $29,182 | $9,673 | 33.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 195 | 210 | $27,664 | $7,324 | 26.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 113 | 116 | $23,617 | $6,828 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 72 | $17,866 | $5,903 | 33.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 70 | 70 | $15,205 | $4,330 | 28.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 150 | 693 | $9,192 | $3,277 | 35.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $7,759 | $2,436 | 31.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 42 | 43 | $4,720 | $1,541 | 32.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 16 | 16 | $4,056 | $1,348 | 33.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 28 | 37 | $3,769 | $1,328 | 35.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 120 | 126 | $22,146 | $7,957 | 35.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 38 | 39 | $8,728 | $3,126 | 35.8% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 34 | 35 | $7,174 | $2,317 | 32.3% |
| 17000 | Destruction of skin growth | Office | 2021 | 60 | 62 | $8,015 | $2,305 | 28.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 30 | 30 | $6,535 | $2,150 | 32.9% |
About Marissa Cunetta, PA-C
Marissa Cunetta, PA-C is a Medical healthcare provider based in Middletown, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2019. The National Provider Identifier (NPI) number assigned to this provider is 1841842622.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marissa Cunetta, PA-C has received a total of $617.63 in payments from pharmaceutical and medical device companies, with $91.27 received in 2024. These payments were reported across 18 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($617.63).
As a Medicare-enrolled provider, Cunetta has provided services to 2,115 Medicare beneficiaries, totaling 3,222 services with total Medicare billing of $110,313. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Other Specialties Surgical
- Location Middletown, RI
- Active Since 07/12/2019
- Last Updated 01/13/2026
- Taxonomy Code 363AM0700X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841842622
Products in Payments
- DUPIXENT (Biological) $222.38
- RINVOQ (Biological) $133.10
- CIBINQO (Drug) $67.07
- ADBRY (Biological) $49.00
- EUCRISA (Drug) $26.52
- Iodosorb Ointment 40g USA (Device) $23.07
- Otezla (Drug) $20.75
- LIGASURE (Device) $14.79
- SKYRIZI (Biological) $7.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Middletown
Richard Whitehead, Pac, PAC
Medical — Payments: $9,182
Medical $9,182
Jared Marshall
Medical — Payments: $6,143
Medical $6,143
Dennise Ramirez, Pa-C, PA-C
Medical — Payments: $2,095
Medical $2,095
Rebbecca Shea, Pa-C, PA-C
Medical — Payments: $1,929
Medical $1,929
Abigail Finkenauer, Pa-C, PA-C
Medical — Payments: $1,453
Medical $1,453
Jignesh Patel, Pa, PA
Medical — Payments: $897.20
Medical $897.20